JUL 29, 2019 12:12 PM PDT

Compound Found in Wine May Treat Anxiety

WRITTEN BY: Nouran Amin

A study published in the journal Neuropharmacology claims that a compound found in red wine could be used as therapeutic for treating anxiety and depression disorders. The compound, called resveratrol, was seen too be involved in anti-stress effects by blocking the expression of an enzyme implicate din stress control of the brain. The study brings new light to how resveratrol is implicated in neurological processes and lays the ground work for future novel antidepressants that re safe and effective.

"Resveratrol may be an effective alternative to drugs for treating patients suffering from depression and anxiety disorders," says Ying Xu, MD, PhD, co-lead author and research associate professor in the UB School of Pharmacy and Pharmaceutical Sciences.

Resveratrol is plant-based and found in the skin and seeds of grapes and berries. Resveratrol has been known to be linked to multiple health benefits including neuroprotection. Recently, research has identified resveratrol’s main mechanism of action by targeting an enzyme known as phosphodiesterase 4 (PDE4)—which is influenced by the stress hormone corticosterone that regulates stress levels. When resveratrol targets PDE4 through inhibiting its actions, it brings antidepressant effects.

“These unknown physiological relationships make drug therapy complex. Current antidepressants instead focus on serotonin or noradrenaline function in the brain, but only one-third of patients with depression enter full remission in response to these medications,” says Xu.

Corticosterone induces excessive amounts of PDE4 in stressed mice and results in depression and anxiety-like behavior. PDE4 is known to reduce cyclic adenosine monophosphate -- a messenger molecule involved in signaling cellular physiological changes such as cell division, change, migration and death. These changes lead to physical alterations in the brain that such disorders begin to develop.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 25, 2019
Drug Discovery & Development
NOV 25, 2019
Darobactin: Promising New Drug to Combat Antibiotic Resistance
Every year, around 700,000 people are estimated to die from drug-resistant infections thanks to our overuse of antibiotics both in agriculture and medicine...
DEC 04, 2019
Neuroscience
DEC 04, 2019
Single Dose Ketamine Could Rewire Alcohol, Drug Dependance
Presentation by Tobias Stephenson about previous research exploring ketamine as an addiction treatment.    Researchers at University College Lond...
DEC 11, 2019
Drug Discovery & Development
DEC 11, 2019
Drug To Treat Ulcerative Colitis
Biomedical researchers at the University of California—Riverside, found that the therapeutic drug ‘tofacitinib’ used in treating autoimmu...
DEC 18, 2019
Drug Discovery & Development
DEC 18, 2019
A tool that simplifies the hunt for cancer drugs
Cells have long been the internal hubs for proteins that hold a wide variety of unique functions. Disorders on how a cell synthesizes a protein can affect ...
JAN 15, 2020
Drug Discovery & Development
JAN 15, 2020
Acid-Reflux Drugs May Negatively Impact Breast Cancer Survivors
Many of us have taken some form of an acid-reflux drug—especially after a meal that causes discomfort. However, now researchers are indicating that s...
FEB 08, 2020
Drug Discovery & Development
FEB 08, 2020
Drug Targets Brain-Eating Amoebas
Brain-eating amoebas lead to high rates of mortality as a result of encephalitis. In fact, more than 95% of people who develop the infection will die. Unfo...
Loading Comments...